{
  "meta": {
    "title": "Plasma_Cell_Disorders_Part_-_2",
    "url": "https://brainandscalpel.vercel.app/plasma-cell-disorders-part-2-18868c86.html",
    "scrapedAt": "2025-11-29T18:32:06.436Z"
  },
  "questions": [
    {
      "id": 15362,
      "choices": [
        {
          "id": 61408,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG</span></span></p>"
        },
        {
          "id": 61409,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA</span></span></p>"
        },
        {
          "id": 61410,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgD</span></span></p>"
        },
        {
          "id": 61411,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male presents with fatigue, weakness, and recurrent infections. Flow cytometry analysis of bone marrow aspirate shows infiltration of small lymphocytes, plasma cells, and lymphoplasmacytoid cells. The patient is diagnosed with lymphoplasmacytoid lymphoma. Which immunoglobulin is most likely to be associated with this lymphoma subtype?</span></span></span></p>",
      "unique_key": "Q2256057",
      "question_audio": null,
      "question_video": null,
      "map_id": 32037,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) IgM </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphoplasmacytoid lymphoma </strong>(or <strong>Waldenstrom&rsquo;s macroglobulinemia) </strong>is a<strong> B cell neoplasm </strong>presenting in 6th or 7th decade of life having features similar to<strong> CLL/ SLL </strong>and <strong>multiple myeloma (MM). </strong>Like MM, there is presence of a <strong>&lsquo;M&rsquo; or monoclonal spike </strong>(caused due to IgM)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>multiple myeloma</strong>, the<strong> M spike </strong>is seen due to<strong> IgG.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (IgG):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While<strong> IgG</strong> is the <strong>most </strong>common <strong>immunoglobulin </strong>produced in <strong>multiple myeloma</strong>, it is not typically associated with lymphoplasmacytoid lymphoma, also known as Waldenstr&ouml;m&rsquo;s macroglobulinemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (IgA):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IgA</strong> is another <strong>immunoglobulin </strong>that can be produced in <strong>multiple myeloma</strong> but is less commonly associated with lymphoplasmacytoid lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (IgD):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>IgD paraproteinemia</strong> is very rare in <strong>plasma cell dyscrasias </strong>and is not commonly seen in lymphoplasmacytoid lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphoplasmacytoid lymphoma, </strong>known as <strong>Waldenstr&ouml;m&rsquo;s macroglobulinemia, </strong>is most commonly associated with the overproduction of<strong> monoclonal IgM</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 604) </span></span></em></strong></span></span></p>",
      "correct_choice_id": 61411,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15364,
      "choices": [
        {
          "id": 61416,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubular casts </span></span></span></p>"
        },
        {
          "id": 61417,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyloidosis </span></span></p>"
        },
        {
          "id": 61418,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wire loop lesions </span></span></p>"
        },
        {
          "id": 61419,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal tubular necrosis </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Q34. A 60-year-old male with a known history of multiple myeloma presents with worsening renal function. A renal biopsy is performed to assess the renal involvement. Which of the following findings would be considered atypical or not commonly associated with renal complications of multiple myeloma?</span></span></span></p>",
      "unique_key": "Q5304409",
      "question_audio": null,
      "question_video": null,
      "map_id": 32038,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Wire loop lesions </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wire loop lesions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Wire loop lesions, seen on<strong> renal biopsy</strong>, are characteristic of<strong> lupus nephritis,</strong> a renal manifestation of <strong>systemic</strong> <strong>lupus erythematosus (SLE).</strong> This finding is <strong>not </strong>typically associated with <strong>multiple myeloma.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Tubular casts:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These can result from the<strong> precipitation of light chains in the renal tubules</strong>, leading to <strong>cast</strong> formation. This is a common finding in<strong> multiple myeloma-associated renal disease.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Amyloidosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Amyloid deposition in the<strong> kidneys is a known complication of multiple myeloma,</strong> leading to <strong>renal</strong> <strong>impairment.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Renal tubular necrosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Direct infiltration of myeloma cells</strong> into the <strong>renal tubules</strong> can cause<strong> tubular necrosis,</strong> contributing to renal dysfunction. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wire loop lesions </strong>are<strong> not typically associated with multiple myeloma</strong> and are characteristic of<strong> lupus nephritis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 225) </span></span></em></strong> </span></span></span></p>",
      "correct_choice_id": 61418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15360,
      "choices": [
        {
          "id": 61400,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia </span></span></p>"
        },
        {
          "id": 61401,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperviscosity </span></span></p>"
        },
        {
          "id": 61402,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone pains </span></span></span></p>"
        },
        {
          "id": 61403,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection </span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the least common presentation of multiple myeloma?</span></span></span></p>",
      "unique_key": "Q7523497",
      "question_audio": null,
      "question_video": null,
      "map_id": 32036,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Hyperviscosity </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Hyperviscosity):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hyperviscosity syndrome is<strong> less commonly </strong>a presenting feature of <strong>multiple myeloma.</strong> It results from the <strong>high</strong> <strong>protein </strong>content in the blood due to excessive production of<strong> monoclonal proteins by myeloma cells,</strong> but not all patients will experience this.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (Anemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Anemia is a common </strong>finding in multiple myeloma, <strong>typically normocytic and normochromic,</strong> caused by the replacement of <strong>bone marrow with myeloma cells</strong>, which impairs normal blood cell production.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (Bone Pains):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Bone pain, </strong>particularly in the <strong>back or chest</strong>, is a <strong>very common</strong> symptom of multiple myeloma. It results from <strong>bone destruction </strong>due to the<strong> infiltration and activation of osteoclasts by myeloma cells,</strong> leading to lytic lesions or fractures.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Infection):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Patients with multiple myeloma have an<strong> increased risk of infections due to an impaired immune response</strong>, both from the disease itself and as a consequence of treatment, making infection a common presentation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperviscosity</strong> is the<strong> least common</strong> presentation of<strong> multiple myeloma compared to anemia, bone pains, and infection.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 609)</span></em></strong></span></span></p>",
      "correct_choice_id": 61401,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15366,
      "choices": [
        {
          "id": 61424,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta 2 microglobulin </span></span></p>"
        },
        {
          "id": 61425,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creatine </span></span></p>"
        },
        {
          "id": 61426,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin </span></span></p>"
        },
        {
          "id": 61427,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia </span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male who is a diagnosed case of multiple myeloma has come up for follow-up. Elevated levels of which of the following is a poor prognostic factor in this patient?</span></span></span></p>",
      "unique_key": "Q1914126",
      "question_audio": null,
      "question_video": null,
      "map_id": 32039,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Beta 2 microglobulin </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated serum levels of <strong>Beta 2 microglobulin</strong> are associated with a <strong>poor prognosis</strong> in multiple myeloma. It is a marker of <strong>tumor</strong> <strong>burden and reflects</strong> the extent of tumor <strong>cell infiltration</strong>. Harrison writes &ldquo;<em><strong>Serum beta 2 microglobulin</strong> is the s<strong>in&shy;gle most powerful</strong> <strong>predictor of survival and can substitute for staging.</strong></em><strong>&rdquo;</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Elevated creatinine levels</strong> can indicate <strong>impaired renal function</strong>, which is a common complication in multiple myeloma. However, it is not a specific prognostic factor on its own.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Low levels of albumin </strong>are associated with <strong>poor prognosis in various diseases,</strong> including multiple myeloma. However, an increase in albumin is not typically considered a poor prognostic factor in this context.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Anemia is a common</strong> feature of<strong> multiple myeloma</strong> and is associated with a <strong>poorer prognosis.</strong> However, the <strong>presence of</strong> <strong>anemia itself</strong> may not necessarily indicate a <strong>worsening prognosis </strong>without considering other factors.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Elevated serum levels of Beta 2 microglobulin </strong>are a <strong>powerful prognostic factor</strong> in multiple myeloma, reflecting tumor burden and the extent of<strong> tumor cell infiltration.</strong></span></span></span></span></span></p>",
      "correct_choice_id": 61424,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}